BSE filing, NSE: RAJATH. Summary written from the filing by ALFA Finder's alert engine.
Fynx Capital Ltd: key numbers
- Share price
- ₹5.70
- Market cap
- ₹114.0 Cr
- Revenue (annual)
- ₹5.06 Cr
- Net profit (annual)
- ₹-3.38 Cr
- P/E (TTM)
- -18.6×Sector 19.7×
- Promoter holding
- 74.90%+0.00% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Fynx Capital Ltd
All →Fynx Capital Capital Structure Change
Fynx Capital filed an in-principle application and draft letter of offer with BSE for a rights issue. The issue aggregates up to ₹80 Crore.
- Value
- ₹80.00 Cr
Fynx Capital Management Change
Fynx Capital Ltd disclosed that statutory auditor N. C. Vaishnav & Co. resigned effective 26 Oct 2026. The departure is cited as capacity constraints, with no other cause.
Fynx Capital Fund Raise of ₹80 Cr
Fynx Capital's board approved a rights issue of up to Rs.80 Crore at a 4:1 ratio. The Rights Issue Committee will approve the draft letter of offer.
- Value
- ₹80.00 Cr
Fynx Capital Q2 FY27 Results: Net Loss of ₹2 Cr, Loss Widens
Fynx Capital Ltd reported revenue from operations of ₹5.7 Cr (+533.3% YoY) and a net loss of ₹2 Cr for Q2 FY27.
- Key figure
- Net loss ₹2 Cr
Fynx Capital Board Meeting Date
Fynx Capital Limited has scheduled a board meeting for October 26, 2026, to consider financial results and a proposal for a ₹80 Crore rights issue.
Fynx Capital Annual General Meeting
FynX Capital Limited held its 41st Annual General Meeting on September 29, 2026. Shareholders approved various resolutions, including financial statements and increased borrowing limits.
Other other announcement announcements
All →eMudhra Other Announcement
eMudhra Ltd disclosed that SES ESG revised its ESG score from 68.0 to 64.9 in its ESG Report 2026. The company states it did not engage SES ESG, and the revision relates to its certificate business.
Aarti Pharmalabs Other Announcement
Aarti Pharmalabs has intimated under Regulation 46 that it revamped its website at the existing URL to improve design and accessibility. The notice has no financial or business substance.
Sagarsoft (India) Other Announcement
Sagarsoft (India) filed its Regulation 32 fund utilisation statement for its 2021 preferential issue. No deviation was reported and the full Rs.5.08 Crore was used.
Sadhana Nitro Chem Other Announcement
Sadhana Nitro Chem reported no deviation in use of its preferential issue proceeds for the quarter ended September 2026. The Audit Committee reviewed the statement.
Shriram Asset Management Company Other Announcement
Shriram AMC filed ICRA's quarterly monitoring agency report on preferential issue proceeds. Utilisation is in line with the offer objects, with no deviation reported.
Jhandewalas Foods Other Announcement
Jhandewalas Foods filed its quarterly shareholding pattern for the period ended September 30, 2026. The filing records holdings by category and contains no transaction or money event.